- CA$10.82bn
- CA$14.26bn
- CA$4.28bn
- 76
- 32
- 98
- 77
Annual income statement for Cae, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,623 | 2,982 | 3,371 | 4,011 | 4,283 |
Cost of Revenue | |||||
Gross Profit | 1,084 | 765 | 956 | 1,084 | 1,155 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,086 | 2,934 | 3,087 | 3,545 | 4,468 |
Operating Profit | 537 | 48.4 | 284 | 466 | -185 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 393 | -87.2 | 154 | 292 | -390 |
Provision for Income Taxes | |||||
Net Income After Taxes | 319 | -47.5 | 150 | 230 | -318 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 311 | -47.2 | 142 | 223 | -304 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 311 | -47.2 | 142 | 223 | -304 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.31 | -0 | 0.862 | 0.84 | 0.466 |
Dividends per Share |